Miracor Medical | Olivier Delporte, CEO


Olivier Delporte

Olivier Delporte

CEO, Miracor Medical
Read Biography
Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO). A novel first-line therapy used during PCI to positively change the course for Acute MI patients.

Olivier Delporte is an international executive with over 20 years of sales, marketing and general management experience, mostly in the medical device industry. Prior to joining Miracor, he was Senior Vice President, Sales & Marketing, U.S. at PneumRx (acquired by BTG in 2015) and Vice President Commercial Operations, Sales and Marketing of Tryton Medical in Europe, Middle East and Africa. Previously, Olivier held leadership positions at Guidant Corporation and Abbott Vascular. Olivier has studied and worked in the U.S., France, Spain, and Belgium. He is currently a Director of Endotoxins Therapeutics. Olivier earned a Master’s Degree in Business from the Université Catholique de Louvain, Belgium, and a Master’s in Business Administration from The University of Chicago Booth School of Business.

LSI USA '24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders in Dana Point.


Share this video

Companies We Work With